Community led health promotion to counter stigma and increase trust amongst priority populations: lessons from the 2022-2023 UK mpox outbreak.

Community led health promotion to counter stigma and increase trust amongst priority populations: lessons from the 2022-2023 UK mpox outbreak.

Publication date: Jun 19, 2024

Stigma, lack of trust in authorities, and poor knowledge can prevent health-seeking behaviour, worsen physical and mental health, and undermine efforts to control transmission during disease outbreaks. These factors are particularly salient with diseases such as mpox, for which 96% of cases in the 2022-2023 UK outbreak were identified among gay, bisexual, queer and men who have sex with men (MSM). This study explored stigma and health-seeking behaviour in Liverpool through the lens of the recent mpox outbreak. Primary sources of data were interviews with national and regional key informants involved in the mpox response, and participatory workshops with priority populations. Workshop recruitment targeted Grindr users (geosocial dating/hookup app) and at risk MSM; immigrant, black and ethnic minority MSM; and male sex workers in Liverpool. Data were analysed using a deductive framework approach, building on the Health Stigma and Discrimination Framework. Key informant interviews (n = 11) and five workshops (n = 15) were conducted. There were prevalent reports of anticipated and experienced stigma due to mpox public health messaging alongside high demand and uptake of the mpox vaccine and regular attendance at sexual health clinics. Respondents believed the limited impact of stigma on health-seeking behaviour was due to actions by the LGBTQ + community, the third sector, and local sexual health clinics. Key informants from the LGBTQ + community and primary healthcare felt their collective action to tackle mpox was undermined by central public health authorities citing under-resourcing; a reliance on goodwill; poor communication; and tokenistic engagement. Mpox communication was further challenged by a lack of evidence on disease transmission and risk. This challenge was exacerbated by the impact of the COVID-19 pandemic on the scientific community, public perceptions of infectious disease, and trust in public health authorities. The LGBTQ + community and local sexual health clinics took crucial actions to counter stigma and support health seeking behaviour during the 2022-2023 UK mpox outbreak. Lessons from rights based and inclusive community-led approaches during outbreaks should be heeded in the UK, working towards more meaningful and timely collaboration between affected communities, primary healthcare, and regional and national public health authorities.

Open Access PDF

Concepts Keywords
Interviews Adult
Lgbtq COVID-19
Liverpool Disease Outbreaks
Pandemic Health Promotion
Homosexuality, Male
Humans
Male
mpox
pandemic preparedness
participatory health research
public health messaging
Qualitative Research
Social Stigma
Trust
United Kingdom

Semantics

Type Source Name
disease VO LACK
drug DRUGBANK Dimethyl sulfone
disease VO vaccine
disease MESH COVID-19 pandemic
disease MESH infectious disease
pathway REACTOME Infectious disease
disease MESH monkeypox
disease MESH zoonotic viral infection
drug DRUGBANK Hexocyclium
disease MESH Vaccinia
disease VO MVA
disease VO smallpox vaccine
disease IDO contact tracing
disease MESH HIV infections
disease MESH lifestyles
disease IDO pathogen
disease VO effective
drug DRUGBANK Coenzyme M
drug DRUGBANK Spinosad
disease IDO process
disease MESH emerging infectious diseases
drug DRUGBANK Trestolone
disease VO population
drug DRUGBANK Aminosalicylic Acid
drug DRUGBANK Etoperidone
drug DRUGBANK Polyethylene glycol
drug DRUGBANK Methionine
disease VO vaccinated
disease VO vaccination
disease MESH infection
disease IDO country
disease VO effectiveness
drug DRUGBANK Ibuprofen
drug DRUGBANK Isoxaflutole
disease MESH uncertainty
disease IDO history
disease MESH AIDS
disease VO Equity
disease MESH measles
pathway KEGG Measles
disease MESH mumps
disease MESH rubella
drug DRUGBANK Serine
disease MESH Emergency
drug DRUGBANK Tecovirimat
drug DRUGBANK Meclofenamic acid
disease VO protocol
disease VO report
disease MESH panic
disease MESH sexually transmitted infection
disease IDO intervention
drug DRUGBANK Benzylpenicillin
drug DRUGBANK Elm
disease MESH Homosexuality
disease MESH Social Stigma

Original Article

(Visited 2 times, 1 visits today)